Alopecia Market (By Disease Type: Alopecia Areata, Androgenetic Alopecia; By End Users: Homecare Settings, Dermatology Clinics; By Distribution Channel: Prescriptions, OTC) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Published | Pages : 160

Alopecia refers to loss of hair from parts of the head or body. Sedentary lifestyle, and unhealthy diets is leading loss of hair among masses. Hormonal miss proportion and aging contribute to rising cases of hair loss. Overall rise in geriatric population and rising awareness and preference for surgical hair transplants and other such treatments is also a positive influence for the global market in the forecast period.

The market research study on “Alopecia Market (By Disease Type: Alopecia Areata, Androgenetic Alopecia; By End Users: Homecare Settings, Dermatology Clinics; By Distribution Channel: Prescriptions, OTC) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026” offers a detailed outlook, strategic recommendations, and insightful viewpoints on the global Alopecia market. The report also analyzes the key players operating in Alopecia market and identifies the key strategies deployed by them along with the market share of leading players.

The global Alopecia market is segmented as below:

Alopecia Market by Disease Type

  • Alopecia Areata
  • Androgenetic Alopecia

Alopecia Market by End Users

  • Homecare Settings
  • Dermatology Clinics

Alopecia Market by Distribution Channel

  • Prescriptions
  • OTC

Alopecia Market by Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • UK
    • France
    • Sweden
    • Norway
    • Denmark
    • Netherlands
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Singapore
    • India
    • Rest of Asia-Pacific
  • Rest of the World
    • UAE
    • Qatar
    • Saudi Arabia
    • South Africa
    • Rest of the World

The global alopecia market is expected to grow at a CAGR of around 5.0%. In 2018, the market was valued at 8.44 billion USD. Product developments are expected to drive the market growth in the near future. Recent product development such as introduction of rapidly acting JAK drugs approved by the U.S. Food and Drug Administration (FDA), developments of methods to stimulate hair growth using human pluripotent stem cells, development of PRP treatment, introduction of a new drug SM04554 which Specifically which stimulate hair growth in men are driving factors. Technological advancements and product like Hairmax Laser Comb, Follinex Massager Comb, Lifemax Infrared Hair Brush and Hair Growth Renewing lasers are some of the products built on advanced technology. The launch of new drugs and the treatment success rate and the clinical outcomes are some of the biggest drives.

The global alopecia market is segmented on the basis of types, end users, and distribution channel. On the basis of disease type, the global market is segmented into alopecia areata, and androgenetic alopecia. On the basis of end users, the market is segmented into homecare settings, dermatology clinics, and others. And on the basis of distribution channel, the market is categorized into prescriptions and OTC.

Geographical the Global Alopecia market is divided into five regions: North America, Europe, Asia Pacific, Latin America, Middle East and Africa.

North America leads the market with and is expected to grow lucratively over the forecast period. Presence of technologically advanced healthcare infrastructure, High disposable income and availability of novel therapeutic options affecting to the treatment are some of the factors contributing to the high market share of North America.

Europe is expected to dominate in the near future owing to outburst of middle-aged population. Asia Pacific has also witnessed growth owning to a large population suffering from Alopecia and rising awareness affecting to the available therapeutic options are the key drivers. Latin America, Middle East and Africa are expected to have a sluggish growth. However, these region are expecting a healthy market growth owing to the huge opportunity for the market growth.

Some of the leading companies operating in the global alopecia market include Cipla,Dr. Reddy’s Laboratories Ltd, Merck & Co.,Viviscal, Regaine, Ranbaxy Laboratories Ltd, Kirkland Signature, Lexington International LLC, Vitabiotics, Alpecin - Dr. Kurt Wolff GmbH & Co, Johnson and Johnson, GlaxoSmithKline PLC


Related Reports

Behavioral Health Market (By Disorder: Alcohol Use Disorders, Schizophrenia, Bipolar Disorder, Depression, Anxiety, Post-traumatic Stress Disorder, Substance Abuse Disorders, Eating Disorders, Others; By Service: Emergency Mental Health Services, Outpatient Counselling, Home-based Treatment Services, Inpatient Hospital Treatment Services, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global Behavioral Health market is forecasted to grow at striking CAGR around 2.5 % over the forecast time frame and reach around US$ 240 billion by 2026. Behavioural health involves non-pharmacological therapies for circumstances like mental health, drug abuse disorder, etc. Due to mental illnesses,

Transcranial Magnetic Stimulator Market (By Type: dTMS, rTMS, Others; By Application: Depression, Epilepsy) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026Transcranial Magnetic Stimulator Market (By Type: dTMS, rTMS, Others; By Application: Depression, Epilepsy) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

The global transcranial magnetic stimulator market size is accounted over USD 2.1 Billion by 2026 and growing at CAGR 9.0% during the forecast period 2019-2026. Transcranial magnetic stimulators are widely used in the treatment of brain and neurological diseases. The transcranial magnetic stimulators is a non-invasive technique which applies magnetic pulses to the brain that uses magnetic field to reduce chronic pain and stimu

Sacral Nerve Stimulation Market (By Product: Implantable, External; By Application: Urinary & Fecal Incontinence, Urge Incontinence, Chronic Anal Fissure, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

The global sacral nerve stimulation market size is expected to reach over 2.3 USD billion by 2026 at the CAGR 12.1% during the forecast period, 2019-2026. A Sacral nerve stimulation is implanted as a device to control bladder functions by delivering controlled electrical impulses to the sacral nerves that modulate the neural pathways. It is an effective and safe treatment for patients suffering fro

Medical Imaging Workstations Market (By Modality: Computed Tomography, MRI, X-ray; By Component: Visualization Software, Display Units; By Usage Mode: Thin, Thick; By Application: Diagnostic Imaging, Clinical Review; By End User: Hospital and Clinics, Diagnostics Centers, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

The global market for Medical Imaging Workstations is estimated to grow at a significant rate of 8.5% during the forecasted period and is expected to reach over 2.3 billion by 2026. Medical imaging workstations are used in the hospitals while setting up the equipments. During last few years there is an significant increase in the prevalence of the various diseases and accidents which has increased

Laser Hair Removal Market (End User: Dermatology Clinics, Beauty Clinics) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

The global laser hair removal market value is accounted over USD 3.9 Billion by 2026 and is expected to grow at CAGR 15.4% during the forecast period 2019-2026. The global laser hair removal product market is driven by increased awareness regarding personal appearance and rising health awareness among the population. Additionally, improved standard of living and rising disposable income tremendously affects the laser hair remo

Idiopathic Pulmonary Fibrosis Treatment Market (By Drug Class: Tyrosine Inhibitors, MAPK Inhibitors, Autotaxin Inhibitors; By End User: Hospitals, Long-term Care Facilities, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

The global Idiopathic Pulmonary Fibrosis Treatment Market is expected to reach over 4.2 USD billion by 2026 and growing at CAGR 11.6% during the forecast period 2019-2026. During last few years, there is a significant increase in the number of respiratory related diseases. Increasing prevalence of the various respiratory diseases, rising geriatric population across the globe, and increasing awareness about health have driven t

Cart Summary